
In Vitro/in Vivo/in Silico Models to Support Bridging Strategies From SC to SC, From IV to SC and Vice Versa
Speaker Presentation: CMC Strategy Forum Europe 2025
Bruin Gerard, Novartis AG, 2025
In Vitro/in Vivo/in Silico Models to Support Bridging Strategies From SC to SC, From IV to SC and Vice Versa